Literature DB >> 26546285

Early- and late-onset Alzheimer disease: Are they the same entity?

P Tellechea1, N Pujol1, P Esteve-Belloch1, B Echeveste1, M R García-Eulate2, J Arbizu3, M Riverol4.   

Abstract

Early-onset Alzheimer disease (EOAD), which presents in patients younger than 65 years, has frequently been described as having different features from those of late-onset Alzheimer disease (LOAD). This review analyses the most recent studies comparing the clinical presentation and neuropsychological, neuropathological, genetic, and neuroimaging findings of both types in order to determine whether EOAD and LOAD are different entities or distinct forms of the same entity. We observed consistent differences between clinical findings in EOAD and in LOAD. Fundamentally, the onset of EOAD is more likely to be marked by atypical symptoms, and cognitive assessments point to poorer executive and visuospatial functioning and praxis with less marked memory impairment. Alzheimer-type features will be more dense and widespread in neuropathology studies, with structural and functional neuroimaging showing greater and more diffuse atrophy extending to neocortical areas (especially the precuneus). In conclusion, available evidence suggests that EOAD and LOAD are 2 different forms of a single entity. LOAD is likely to be influenced by ageing-related processes.
Copyright © 2015 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Early-onset; Enfermedad de Alzheimer; Inicio precoz; Inicio tardío; Late-onset; Neuroimagen; Neuroimaging; Neuropathology; Neuropatología; Neuropsicología; Neuropsychology

Mesh:

Year:  2015        PMID: 26546285     DOI: 10.1016/j.nrl.2015.08.002

Source DB:  PubMed          Journal:  Neurologia (Engl Ed)        ISSN: 2173-5808


  22 in total

Review 1.  Alzheimer's disease: experimental models and reality.

Authors:  Eleanor Drummond; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2016-12-26       Impact factor: 17.088

2.  Unified framework for brain connectivity-based biomarkers in neurodegenerative disorders.

Authors:  Sung-Woo Kim; Yeong-Hun Song; Hee Jin Kim; Young Noh; Sang Won Seo; Duk L Na; Joon-Kyung Seong
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

3.  Causes of Death after Prostate Cancer Diagnosis: A Population-Based Study.

Authors:  Yadong Guo; Xiaohui Dong; Shiyu Mao; Fuhan Yang; Ruiliang Wang; Wenchao Ma; Ji Liu; Cheng Li; Zongtai Zheng; Wentao Zhang; Aihong Zhang; Xudong Yao
Journal:  Oxid Med Cell Longev       Date:  2022-04-23       Impact factor: 7.310

Review 4.  Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.

Authors:  Ranjan Duara; Warren Barker
Journal:  Neurotherapeutics       Date:  2022-01-27       Impact factor: 6.088

Review 5.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

6.  Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.

Authors:  Sarah Gourmaud; Haochang Shou; David J Irwin; Kimberly Sansalone; Leah M Jacobs; Timothy H Lucas; Eric D Marsh; Kathryn A Davis; Frances E Jensen; Delia M Talos
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

Review 7.  Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia? Review of Key Points Toward an Accurate Clinical and Neuropsychological Diagnosis.

Authors:  Gada Musa; Andrea Slachevsky; Carlos Muñoz-Neira; Carolina Méndez-Orellana; Roque Villagra; Christian González-Billault; Agustín Ibáñez; Michael Hornberger; Patricia Lillo
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

8.  A Genome-Wide Study of Single-Nucleotide Polymorphisms in MicroRNAs and Further In Silico Analysis Reveals Their Putative Role in Susceptibility to Late-Onset Alzheimer's Disease.

Authors:  Soraya Herrera-Espejo; Borja Santos-Zorrozua; Paula Alvarez-Gonzalez; Idoia Martin-Guerrero; Marian M de Pancorbo; Africa Garcia-Orad; Elixabet Lopez-Lopez
Journal:  Mol Neurobiol       Date:  2020-09-06       Impact factor: 5.590

Review 9.  The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.

Authors:  Heather H C Lau; Martin Ingelsson; Joel C Watts
Journal:  Acta Neuropathol       Date:  2020-08-02       Impact factor: 17.088

Review 10.  Sex differences in the incidence and prevalence of young-onset Alzheimer's disease: A meta-analysis.

Authors:  Geeske Peeters; Katerine Katelekha; Brian Lawlor; Naiara Demnitz
Journal:  Int J Geriatr Psychiatry       Date:  2021-08-12       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.